kynurenine and olanzapine

kynurenine has been researched along with olanzapine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Dahl, ML; Engberg, G; Erhardt, S; Holtze, M; Linderholm, KR; Olsson, SK; Samuelsson, M; Skogh, E1
Khanam, R; Thomas, J; Vohora, D1
Oxenkrug, G; Summergrad, P1
Guan, X; Li, X; Liu, H; Wu, F; Xiu, M; Xu, J1

Other Studies

4 other study(ies) available for kynurenine and olanzapine

ArticleYear
Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
    Schizophrenia bulletin, 2012, Volume: 38, Issue:3

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Olanzapine; Schizophrenia; Tryptophan; Up-Regulation; Young Adult

2012
Activation of indoleamine 2, 3- dioxygenase pathway by olanzapine augments antidepressant effects of venlafaxine in mice.
    Psychiatry research, 2017, Volume: 258

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depression; Depressive Disorder, Treatment-Resistant; Female; Hippocampus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Interleukin-1beta; Interleukin-6; Kynurenine; Male; Mice; Olanzapine; Serotonin; Stress, Psychological; Swimming; Tryptophan; Venlafaxine Hydrochloride

2017
Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j Mice.
    Molecular neurobiology, 2020, Volume: 57, Issue:1

    Topics: Animals; Antipsychotic Agents; Benserazide; Dyslipidemias; Female; Insulin Resistance; Kynurenine; Metabolic Syndrome; Mice, Inbred C57BL; Obesity; Olanzapine; Weight Gain

2020
Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study.
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:10

    Topics: Antipsychotic Agents; Benzodiazepines; Chromatography, Liquid; Female; Humans; Kynurenine; Longitudinal Studies; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Tandem Mass Spectrometry; Treatment Outcome

2022